Semisynthetic anti-malaria drug from Sanofi is shipped to Africa

08/13/2014 | BioSpectrum Asia

The first large shipments of a new anti-malaria drug using a semisynthetic artemisinin derivative have been delivered to countries in Africa through a partnership between French drugmaker Sanofi and global health organization PATH. The semisynthetic artemisinin has been shown to be an exact replica of the botanically derived version, giving the new drug the same level of effectiveness.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY